Global Digital Health Unit, Department of Primary Care and Public Health, Imperial College London, London, UK.
Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, UK.
J Antimicrob Chemother. 2022 Feb 23;77(3):782-792. doi: 10.1093/jac/dkab440.
Escherichia coli are Gram-negative bacteria associated with an increasing burden of antimicrobial resistance (AMR) in England.
To create a comprehensive epidemiological picture of E. coli bacteraemia resistance trends and risk factors in England by linking national microbiology data sources and performing a longitudinal analysis of rates.
A retrospective observational study was conducted on all national records for antimicrobial susceptibility testing on E. coli bacteraemia in England from 1 January 2013 to 31 December 2018 from the UK Health Security Agency (UKHSA) and the BSAC Resistance Surveillance Programme (BSAC-RSP). Trends in AMR and MDR were estimated using iterative sequential regression. Logistic regression analyses were performed on UKHSA data to estimate the relationship between risk factors and AMR or MDR in E. coli bacteraemia isolates.
An increase in resistance rates was observed in community- and hospital-onset bacteraemia for third-generation cephalosporins, co-amoxiclav, gentamicin and ciprofloxacin. Among community-acquired cases, and after adjustment for other factors, patients aged >65 years were more likely to be infected by E. coli isolates resistant to at least one of 11 antibiotics than those aged 18-64 years (OR: 1.21, 95% CI: 1.18-1.25; P < 0.05). In hospital-onset cases, E. coli isolates from those aged 1-17 years were more likely to be resistant than those aged 18-64 years (OR: 1.33, 95% CI: 1.02-1.73; P < 0.05).
Antibiotic resistance rates in E. coli-causing bacteraemia increased between 2013 and 2018 in England for key antimicrobial agents. Findings of this study have implications for guiding future policies on a prescribing of antimicrobial agents, for specific patient populations in particular.
大肠杆菌是一种革兰氏阴性细菌,与英国不断增加的抗生素耐药性(AMR)负担有关。
通过链接国家微生物学数据来源并对比率进行纵向分析,创建大肠杆菌菌血症耐药趋势和危险因素的综合流行病学图。
对英国卫生安全局(UKHSA)和抗菌药物敏感性试验(ABST)的所有国家记录进行回顾性观察研究。2013 年 1 月 1 日至 2018 年 12 月 31 日,英格兰从英国卫生安全局(UKHSA)和抗菌药物敏感性试验(ABST)的所有国家记录中进行了研究。使用迭代顺序回归估计 AMR 和 MDR 的趋势。对 UKHSA 数据进行逻辑回归分析,以估计大肠杆菌菌血症分离株中危险因素与 AMR 或 MDR 之间的关系。
观察到社区和医院获得性菌血症中第三代头孢菌素、复方新诺明、庆大霉素和环丙沙星的耐药率上升。在社区获得性病例中,在调整其他因素后,年龄>65 岁的患者比 18-64 岁的患者更有可能感染至少一种 11 种抗生素耐药的大肠杆菌分离株(OR:1.21,95%CI:1.18-1.25;P<0.05)。在医院获得性病例中,年龄 1-17 岁的患者的大肠杆菌分离株比 18-64 岁的患者更有可能耐药(OR:1.33,95%CI:1.02-1.73;P<0.05)。
2013 年至 2018 年间,英格兰大肠杆菌引起的菌血症中关键抗菌药物的耐药率有所上升。本研究的结果对指导未来针对特定人群(特别是特定患者群体)的抗菌药物处方政策具有重要意义。